1887
  1. Home
  2. Eurosurveillance
  3. Volume 29, Issue 29, 18/Jul/2024
  4. Article
Research Open Access
Like 0
Download

SDG goal 3: hepatitis

Abstract

Background

Active follow-up of chronic hepatitis C notifications to promote linkage to care is a promising strategy to support elimination.

Aim

This pilot study in Victoria, Australia, explored if the Department of Health could follow-up on hepatitis C cases through their diagnosing clinicians, to assess and support linkage to care and complete data missing from the notification.

Methods

For notifications received between 1 September 2021 and 31 March 2022 of unspecified hepatitis C cases (i.e. acquired > 24 months ago or of unknown duration), contact with diagnosing clinicians was attempted. Data were collected on risk exposures, clinical and demographic characteristics and follow-up care (i.e. HCV RNA test; referral or ascertainment of previous negative testing or treatment history). Reasons for unsuccessful doctor contact and gaps in care provision were investigated. Advice to clinicians on care and resources for clinical support were given on demand.

Results

Of 513 cases where information was sought, this was able to be obtained for 356 (69.4%). Reasons for unsuccessful contact included incomplete contact details or difficulties getting in touch across three attempts, particularly for hospital diagnoses. Among the 356 cases, 307 (86.2%) had received follow-up care. Patient-management resources were requested by 100 of 286 contacted diagnosing clinicians.

Conclusions

Most doctors successfully contacted had provided follow-up care. Missing contact information and the time taken to reach clinicians significantly impeded the feasibility of the intervention. Enhancing system automation, such as integration of laboratory results, could improve completeness of notifications and support further linkage to care where needed.

© Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2024.29.29.2400028
2024-07-18
2024-12-22
/content/10.2807/1560-7917.ES.2024.29.29.2400028
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/29/29/eurosurv-29-29-3.html?itemId=/content/10.2807/1560-7917.ES.2024.29.29.2400028&mimeType=html&fmt=ahah

References

  1. Hong TP, Gow PJ, Fink M, Dev A, Roberts SK, Nicoll A, et al. Surveillance improves survival of patients with hepatocellular carcinoma: a prospective population-based study. Med J Aust. 2018;209(8):348-54.  https://doi.org/10.5694/mja18.00373  PMID: 30309301 
  2. Kirby Institute. HIV, viral hepatitis and sexually transmissible infections in Australia Annual surveillance report 2021: Hepatitis C. Sydney: The Kirby Institute, The University of New South Wales, 2021.
  3. Cancer Council Australia. Roadmap to Liver Cancer Control in Australia. 2023.
  4. Hepatitis C Virus Infection Consensus Statement Working Group. Australian recommendations for the management of hepatitis C virus infection: a consensus statement (June 2020). Melbourne: Gastroenterological Society of Australia; 2020.
  5. MacLachlan J, Stewart S, Cowie B. Viral Hepatitis Mapping Project: Geographic diversity in chronic hepatitis B and C prevalence, management and treatment. National Report 2020. Darlinghurst, NSW, Australia; 2021.
  6. Australian Government Department of Health. Fifth National Hepatitis C Strategy 2018-2022 Canberra: Australian Government Department of Health; 2018. [Accessed 11 Feb 2024]. Available from: https://www.health.gov.au/resources/publications/fifth-national-hepatitis-c-strategy-2018-2022?language=en
  7. MacLachlan JH, Romero N, Higgins N, Coutts R, Chan R, Stephens N, et al. Epidemiology of chronic hepatitis B and C in Victoria, Australia: insights and impacts from enhanced surveillance. Aust N Z J Public Health. 2020;44(1):59-64.  https://doi.org/10.1111/1753-6405.12934  PMID: 31535439 
  8. Marrone S. Understanding barriers to health care: a review of disparities in health care services among indigenous populations. Int J Circumpolar Health. 2007;66(3):188-98.  https://doi.org/10.3402/ijch.v66i3.18254  PMID: 17655060 
  9. Harris M, Rhodes T. Hepatitis C treatment access and uptake for people who inject drugs: a review mapping the role of social factors. Harm Reduct J. 2013;10(1):7.  https://doi.org/10.1186/1477-7517-10-7  PMID: 23651646 
  10. Khatri RB, Assefa Y. Access to health services among culturally and linguistically diverse populations in the Australian universal health care system: issues and challenges. BMC Public Health. 2022;22(1):880.  https://doi.org/10.1186/s12889-022-13256-z  PMID: 35505307 
  11. World Health Organization (WHO). Global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022-2030. Geneva: WHO; 2022.
  12. Australian Government Department of Health. Australian national notifiable diseases and case definitions 2017. [Accessed 6 Jun 2024]. Available from: http://www.health.gov.au/internet/main/publishing.nsf/Content/cdna-casedefinitions.htm
  13. Hepatitis C Virus Infection Consensus Statement Working Group. Australian recommendations for the management of hepatitis C virus infection: a consensus statement (2022). Melbourne: Gastroenterological Society of Australia, 2022.
  14. King J, McManus H, Kwon J, Gray R, McGregor S. HIV, viral hepatitis and sexually transmissible infections in Australia Annual surveillance report 2023: Hepatitis C. Sydney: The Kirby Institute, The University of New South Wales; 2023.
  15. Australian Government Department of Health and Ageing. Medicare Benefits Schedule, May 2013: Australian Government, Department of Health and Ageing; 2013 [21 April 2013]. Available from: http://www9.health.gov.au/mbs/fullDisplay.cfm?type=note&qt=NoteID&q=A30
  16. Communicable Diseases Network Australia (CDNA). Hepatitis C (newly acquired) case definition: Australian Government Department of Health 2023. [Accessed 17 Nov 2023]. Available from: https://www.health.gov.au/resources/publications/hepatitis-c-newly-acquired-surveillance-case-definition?language=en
  17. Communicable Diseases Network Australia (CDNA). Hepatitis C (unspecified) case definition: Australian Government Department of Health 2023. [Accessed 17 Nov 2023]. Available from: https://www.health.gov.au/resources/publications/hepatitis-c-unspecified-surveillance-case-definition?language=en
  18. Snow K, Scott N, Clothier HJ, MacLachlan JH, Cowie B. Limited provision of diagnostic services to Victorians living with hepatitis C antibodies, 2001-2012: a multi-level modelling analysis. Aust N Z J Public Health. 2017;41(2):193-8.  https://doi.org/10.1111/1753-6405.12560  PMID: 27523715 
  19. Fielding J. Infectious diseases notification trends and practices in Victoria, 2009. Victorian Infectious Diseases Bulletin.2010;13(3):86-90.
  20. Australian Government Department of Health. Schedule of Pharmaceutical Benefits June 2021 Canberra: Commonwealth of Australia; 2021. Available from: http://www.pbs.gov.au/info/browse/publications
  21. Victorian Government Department of Health. Victorian integrated hepatitis C services: nurse led models of care 2022. Available from: https://www.health.vic.gov.au/preventive-health/victorian-integrated-hepatitis-c-services-nurse-led-models-of-care
  22. Gooey M, Wong E, Pedrana A, Allard N, Doyle J, Hellard M, et al. A survey of Australian general practitioners’ hepatitis C knowledge and management 2 years after subsidised direct-acting antiviral therapy became available. Sex Health. 2020;17(4):387-9.  https://doi.org/10.1071/SH19189  PMID: 32693908 
  23. World Health Organisation (WHO). Global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022-2030. Geneva: WHO, 2022.
  24. Walker S, Wallace J, Latham N, Saich F, Pedrana A, Hellard M, et al. "It’s time!": A qualitative exploration of the acceptability of hepatitis C notification systems to help eliminate hepatitis C. Int J Drug Policy. 2021;97:103280.  https://doi.org/10.1016/j.drugpo.2021.103280  PMID: 34058670 
  25. WHO Collaborating Centre for Viral Hepatitis at The Doherty Institute. CHECCS Project Evaluation Report Melbourne: The Doherty Institute; 2022. Available from: https://www.doherty.edu.au/whoccvh/centre-activities/checcs
  26. Victorian Government. Pandemic Code Brown To Support Hospitals 2022. Available from: https://www.premier.vic.gov.au/pandemic-code-brown-support-hospitals
  27. Lifeblood ARC. Blood testing and safety 2023. Available from: https://www.lifeblood.com.au/blood/blood-testing-and-safety
  28. Australian Bureau of Statistics. Australian Statistical Geography Standard. 2016;1(July):2016. Available from: https://www.abs.gov.au/statistics/standards/australian-statistical-geography-standard-asgs-edition-3/latest-release
  29. Australian Bureau of Statistics. Snapshot of Victoria. Canberra: Commonwealth of Australia; 2022.
  30. O’Brien ER, Whelan MC, Lama T, Levy M. Public Health Unit notifications of hepatitis C and their follow-up in South Western Sydney, Australia. Public Health Res Pract. 2021;31(3):30342010.  https://doi.org/10.17061/phrp30342010  PMID: 34494075 
  31. The Burnet Institute. Using hepatitis C notification data to increase access to hepatitis C treatment and cure in Australia: A formative study. 2022.
  32. Marukutira T, Barter R, Moore KP, Hellard ME, Richmond J, Turner K, et al. Connecting patients notified with hepatitis C to treatment (CONNECT Study): A randomized controlled trial of active case management by a health department to support primary care practitioners. Int J Drug Policy. 2023;121:104184.  https://doi.org/10.1016/j.drugpo.2023.104184  PMID: 37714008 
  33. Isfordink CJ, van Dijk M, Brakenhoff SM, Kracht PAM, Arends JE, de Knegt RJ, et al. , CELINE Study Group. Hepatitis C Elimination in the Netherlands (CELINE): How nationwide retrieval of lost to follow-up hepatitis C patients contributes to micro-elimination. Eur J Intern Med. 2022;101:93-7.  https://doi.org/10.1016/j.ejim.2022.04.024  PMID: 35527178 
  34. Morales-Arraez D, Hernández-Bustabad A, Reygosa Castro C, Benitez-Zafra F, Nicolás-Pérez D, Crespo O, et al. Reengagement strategies for hepatitis C patients lost to follow-up: A randomized clinical trial. Hepatol Commun. 2023;7(6):e0080.  https://doi.org/10.1097/HC9.0000000000000080  PMID: 37204411 
  35. European Centre for Disease Prevention and Control (ECDC). Hepatitis C Annual Epidemiological Report for 2022. Stockholm: ECDC; 2024.
  36. Public Health and Wellbeing Act, Parliament of Victoria (2008); 2008.
A pilot project harnessing surveillance systems to support clinicians providing clinical care for people diagnosed with hepatitis C in Victoria, Australia, September 2021 to 31 March 2022
<p class="citation"> <span>Citation style for this article:</span> <span class="meta-value authors"> <a href="/search?value1=Mielle+Abbott&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Abbott Mielle</a>, <a href="/search?value1=Jennifer+H+MacLachlan&option1=author&noRedirect=true" class="nonDisambigAuthorLink">MacLachlan Jennifer H</a>, <a href="/search?value1=Nicole+Romero&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Romero Nicole</a>, <a href="/search?value1=Nicole+Matthews&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Matthews Nicole</a>, <a href="/search?value1=Nasra+Higgins&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Higgins Nasra</a>, <a href="/search?value1=Alvin++Lee&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Lee Alvin </a>, <a href="/search?value1=Mark+Stoove&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Stoove Mark</a>, <a href="/search?value1=Tafireyi+Marukutira&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Marukutira Tafireyi</a>, <a href="/search?value1=Brendan+Quinn&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Quinn Brendan</a>, <a href="/search?value1=Nicole+L+Allard&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Allard Nicole L</a>, <a href="/search?value1=Benjamin+C+Cowie&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Cowie Benjamin C</a></span>. A pilot project harnessing surveillance systems to support clinicians providing clinical care for people diagnosed with hepatitis C in Victoria, Australia, September 2021 to 31 March 2022. <a href="/content/ecdc">Euro Surveill.</a> 2024;29(29):pii=2400028. <a href="https://doi.org/10.2807/1560-7917.ES.2024.29.29.2400028" title="doi link" target="_blank">https://doi.org/10.2807/1560-7917.ES.2024.29.29.2400028</a> <span class="ES_Article_citation"> <span class="generated">Received</span>: 09 Jan 2024;&nbsp;&nbsp; <span class="generated">Accepted</span>: 17 Jun 2024 </span> </p>
/content/10.2807/1560-7917.ES.2024.29.29.2400028
/content/10.2807/1560-7917.ES.2024.29.29.2400028
Loading

Data & Media loading...

Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error